Skip to content

336.522.8870Monday – Friday 7:45 AM – 4:15 PM

PulmonIx Research LLC

Transforming clinical care through cutting-edge research

Home
About Us
For Patients
For Sponsors
- Metrics
- Certifications
Employment
Contact Us
- Contact
- Travel Info

Search:

Home
About Us
For Patients
For Sponsors
- Metrics
- Certifications
Employment
Contact Us
- Contact
- Travel Info

New COPD Triple Inhaler

New COPD triple inhaler, Trelegy, approved for COPD exacerbations – PI: Murali Ramaswamy.

Read Full Article

Category: NewsBy Pulmonix May 3, 2018

Post navigation

NextNext post:Dupulimab – New Class Agent Injectable in Asthma

Related Posts

Effect of Antifibrotic Therapy on Survival in Patients With Idiopathic Pulmonary Fibrosis
March 30, 2023

pulmonary fibrosis month

September is Pulmonary Fibrosis Awareness Month #PFAM2022 and #BlueUpForPF
September 26, 2022

Importance of Clinical Trials
August 26, 2022

Cone Health Medical Staff Honors Its ‘Health Care Heroes’
October 6, 2021

© PulmonIx Research, LLC 2024 | Site by Lazuli Creative